Since 1998, drug companies have spent $758 million on lobbying -- more than any other industry. That is over half a billion dollars that have a dramatic influence on how drugs are viewed politically.
Since the government ultimately determines which products drug companies can market and how they're labeled, their lobbying is really having a serious impact on you. So, with the drug industry facing the possibility of increased regulation -- due to mounting concerns about the safety of the nation's drug supply -- many drug companies are doing whatever it takes to wine and dine members of Congress to lean in their favor.
For example, the drug companies' corporate planes have been made available for dozens of trips taken by powerful lawmakers. The absolute clincher, however, is the amount of money drug companies are willing to spend in order to protect themselves and their drugs for meeting their doom.
Big Spenders
Drug companies and their officials contributed at least $17 million to federal candidates in last year's elections, including:
And if that doesn't seem like enough schmoozing, consider this fact again: Drug companies have spent more than $750 million over the past seven years on lobbying alone. According to government records analyzed by the Center for Public Integrity, that's more than any other industry!
Lobbyists' Political Success
The drug industry employs almost 1,274 lobbyists, including 40 former members of Congress. Over the years those lobbyists have been extremely successful, proving they know politics just as well as they know chemistry. Specifically, they've:
Won coverage for prescription drugs under Medicare in 2003 while preventing the government from negotiating prices downward.
So far kept out imports of cheaper medicines from Canada and other countries.
Protected a system that uses company fees to speed the drug-approval process.
Unfortunately, this information serves as a sad reminder of just how deeply the mega-pharmaceutical industry influenceswhat is seen and heard in the media.
USA Today April 26, 2005
If you want to know why I believe the drug companies have too great of an influence over the health of Americans you need to look no further than the above article. It is a perfect illustration of why our health care system is so fatally flawed.
The drug companies are manipulating the government involvement with medicine and secondarily reinforcing our dependence on them, through government policies.
Although the dollars the mega-pharmaceutical companies spent on lobbying alone -- more than $750 million over the past seven years -- are astronomical by most people's standards, they pale in comparison to the profits this industry generates -- even though the drug companies spend more on lobbying than any other industry.
The Medicare Drug Bill is a classic example of how the drug companies' lobbying efforts can have significant and powerful influence over using government subsidies to directly support the drug companies. A bill that was supposed to cost a measly $400 billion over a decade has now grown to more than $1 trillion. Almost makes that $750 million seem, by comparison, like a drop in the bucket.
If you previously had any doubts about how the drug companies are buying their way into your pocket, this article is one of the best I have seen to date on the subject. Please click on the USA Today link to read the entire article and you will begin to more fully appreciate the extent of how it's occurring. It is information like this that fuels my vision to spearhead a movement to replace the existing, broken health care paradigm, focused on drug-based solutions for curing conditions, and replace it with one that emphasizes prevention and treats the true causes of disease.
Related Articles:
How Could Drug Companies Be So Evil? Members of Congress Face Conflict of Interest When it Comes to Drug Companies Why is the Government Protecting the Drug Companies?
How Could Drug Companies Be So Evil?
Members of Congress Face Conflict of Interest When it Comes to Drug Companies
Why is the Government Protecting the Drug Companies?